AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker ...
British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development ...
March 21 (UPI) --AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational pharmaceutical announced Friday. The investment will mark the ...
AstraZeneca Pharma India Ltd on Monday said it has received approval from drug regulator CDSCO to import and distribute cancer treatment medicine Durvalumab solutions in the country. The approval ...
LONDON (Reuters) - AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker scrambles to revive business in its second-biggest market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results